Doc's note: Are tech stocks already in a mania? That's the question on a lot of traders' minds.

Today, Brett Eversole – editor of DailyWealth – looks at a contrarian signal that shows tech stocks can still move higher from here...

It probably feels like we're living in a frothy market...

SpaceX (SPCX) went public at a $1.8 trillion valuation. That's about 100 times last year's sales. But that massive valuation didn't stop the stock from jumping more than 50% in its first few days of trading.

You'd expect to only see this in a market mania, right?

Well, not quite.

SpaceX might be a great mania example of speculative enthusiasm. But it doesn't represent the entire market.

If we look at tech stocks as a whole, we see the opposite of froth. Futures traders haven't been this bearish on tech since 2020. And according to history, that negativity is setting up another big move higher.

Let me explain...

The Contrarian Signal Pointing to Further Upside

You can get a read on sentiment by asking investors how they feel. But that'll only get you so far. People lie. They often hide their true feelings... Or they might believe one thing but do another.

As author and hedge-fund manager Nassim Taleb famously said, "Don't tell me what you think, tell me what you have in your portfolio."

The best way to gauge sentiment is to track what people are actually doing with their money. That's why we often look at the futures market and the Commitment of Traders ("COT") report.

This weekly report shows how futures traders are positioned. It's also a useful contrarian indicator... because when these folks all agree, they're usually wrong.

Right now, futures traders are betting against the tech-heavy Nasdaq 100 Index at nearly the highest rate in history. Take a look...

Futures traders were wildly bullish on the Nasdaq 100 in late 2025. But sentiment has collapsed since then. Today, they're more bearish than at any point besides the 2020 market panic.

That's a powerful contrarian signal. And history shows that tech stocks could keep moving higher from here.

To see why, I looked at each new 52-week low in the Nasdaq 100's COT report. We've seen 11 other instances since the data begins in mid-2010. And each sentiment low was a powerful buying opportunity. Take a look...

The post-financial-crisis boom in technology has been one for the record books. The Nasdaq 100 is up 18.9% a year since mid-2010. But investors who bought when futures traders were the most bearish did even better...

Those setups led to gains of 8.2% in three months, 12% in six months, and 23.9% in a year. Plus, the Nasdaq 100 was higher a year later 100% of the time.

Sure, it's easy to find crazy behavior in today's market. But a few wild anecdotes don't explain the big picture.

As surprising as it might be, futures traders are darn bearish on tech right now. From a contrarian perspective, that's exactly the kind of skepticism that can fuel the next leg higher.

This market won't peak until everyone is "all in." We're not there yet... which means this bull market can still move much higher.

Good investing,

Brett Eversole

Editor's note: The biggest story in tech this year is the continuing AI boom. This Thursday, Luke Lango (from our corporate affiliate InvestorPlace) will host the 2026 AI Megadeal Event where he will reveal the secretive opportunity that lets you profit off the biggest AI breakthroughs in the world... Without touching a single volatile AI stock.

Click here to claim your spot.

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top